In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Eiger Bio Pharmaceuticals, Inc.. Trade Record

NASDAQ:EIGR Eiger Bio Pharmaceuticals, Inc. stock gains 29.00% Exit Sep 21, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart EIGR Aug 28, 2017, priceSeries
About Eiger Bio Pharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. It portfolio of products include Sarasar, an indication for the hepatitis delta virus infection; Exendin, which is used for the treatment of hypoglycemia associated with bariatric surgery; and Bestatin that is used for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. The company was founded in 2008 and is headquartered in Palo Alto, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
97.44
Entry Date
Aug 28, 2017
Entry Price
8.20
Sell Date
Sep 21, 2017
Sell Price
10.58
Net Gain
29.00%
Hold Time
17 Trading Days